Enveloped virus is the major virus form produced during productive infection with the modified vaccinia virus Ankara strain.
Modified vaccinia virus Ankara (MVA) is a highly attenuated virus strain that may be useful as a vaccine vector. Ultrastructural examination of purified MVA showed that most of the viral particles are enveloped in contrast to the Copenhagen strain (COP). In CsCl gradients, the majority of the MVA particles displayed a light buoyant density characteristic of the enveloped form. Consistent with these results, MVA particles were poorly labeled with antibodies against the surface of intracellular mature virus but strongly labeled with antibodies against an envelope antigen. Furthermore, MVA was more resistant than the COP strain to neutralization by mouse anti-COP antibodies. These results suggest that the MVA strain may be particularly suitable for the engineering of envelope proteins and that MVA may be able to resist the humoral immunity displayed by previously vaccinated individuals.
Spehner
D
D
Equipe Propre INSERM 99-08, Transgène, du Sang-Alsace, Strasbourg, France.
Drillien
R
R
Proamer
F
F
Houssais-Pêcheur
C
C
Zanta
M A
MA
Geist
M
M
Dott
K
K
Balloul
J M
JM
D000818:Animals; D000914:Antibodies, Viral / Q000276:immunology; D002478:Cells, Cultured; D002499:Centrifugation, Density Gradient; D002642:Chick Embryo; D006224:Cricetinae; D005347:Fibroblasts; D051379:Mice; D008854:Microscopy, Electron; D008968:Molecular Conformation; D009500:Neutralization Tests; D014613:Vaccines, Attenuated / Q000737:chemistry; D014616:Vaccinia virus / Q000737:chemistry / Q000145:classification* / Q000502:physiology / Q000648:ultrastructure*; D014759:Viral Envelope Proteins / Q000737:chemistry* / Q000276:immunology / Q000378:metabolism*; D019065:Virus Assembly
D000914:Antibodies, Viral; D014613:Vaccines, Attenuated; D014759:Viral Envelope Proteins